Teladoc Health, Inc. provides business-to-business virtual health care services in the United States and internationally. The company is headquartered in Purchase, New York.
| Revenue (TTM) | $2.51B |
| Gross Profit (TTM) | $1.74B |
| EBITDA | $47.51M |
| Operating Margin | -7.94% |
| Return on Equity | -12.40% |
| Return on Assets | -3.14% |
| Revenue/Share (TTM) | $14.17 |
| Book Value | $7.41 |
| Price-to-Book | 1.19 |
| Price-to-Sales (TTM) | 0.63 |
| EV/Revenue | 0.744 |
| EV/EBITDA | 8.71 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -2.50% |
| Shares Outstanding | $180.51M |
| Float | $179.34M |
| % Insiders | 0.69% |
| % Institutions | 83.73% |
Volatility is currently expanding
Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights. We would handle the matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Teladoc (TDOC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.
TORONTO--(BUSINESS WIRE)--Teladoc Health Canada (Teladoc) has achieved the Accreditation Canada Primer Award, providing independent validation of its commitment to delivering safe, high-quality, and patient-centred virtual and hybrid care for Canadians. As one of the first virtual acute care programs assessed against Accreditation Canada's standard of excellence, Teladoc is helping advance how clinical quality and patient safeguards are evaluated in evolving models of care. The Primer Award rec.
Teladoc One is a model of care delivered as a single, predictive and adaptive experience to drive better health outcomes and address the rising total cost of care
The latest trading day saw Teladoc (TDOC) settling at $9.65, representing a +2.33% change from its previous close.
NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release second quarter 2026 results on Wednesday, July 29, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day.
Teladoc (TDOC) closed the most recent trading day at $9.21, moving +1.54% from the previous trading session.
Hims & Hers Health continues to drive impressive growth through its subscription-based consumer wellness platform. Teladoc Health maintains a dominant market share with over 100 million global members and significant institutional partnerships.
NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee.
Teladoc's business is slowly improving due to several initiatives. However, the company still faces potential headwinds that could derail its progress.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on TDOC and any ticker you trade — then tracks every position and per-strategy win rate.
